{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:39:14Z","timestamp":1791851954900,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to analyze the clinical data within one year of the patients who underwent hysteroscopic endometrial polypectomy with levonorgestrel-releasing intrauterine system (LNG-IUS) insertion, and to identify the risk factors affecting the duration of irregular uterine bleeding pattern (IUBP), trying to build models predicting this period and evaluate the performance of the models, in order to shorten the IUBP duration through intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical data were collected from 245 patients who underwent hysteroscopic endometrial polypectomy and LNG-IUS placement at our hospital between January 2018 and December 2022. The data, recorded within one year after LNG-IUS insertion, included age, the number of polyps, preoperative endometrial thickness, maximum polyp diameter, the timing of LNG-IUS placement, LNG-IUS expulsion and migration, coital bleeding, pelvic pain, amenorrhea, irregular uterine bleeding pattern, and polyp recurrence. The differences of adverse reactions were analyzed by age and LNG-IUS placement timing stratified. Logistic regression model and Generalized Additive Model (GAM) were established to predict the duration of irregular uterine bleeding after LNG-IUS insertion, and attempts were made to explore the relationship between the variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Age was the independent risk factor for amenorrhea after LNG-IUS insertion, the patients with aged\u2009\u2265\u200940\u00a0years were more likely to experience amenorrhea (P\u2009&lt;\u20090.05). No significant difference was observed between patients who had LNG-IUS placement at surgery immediately and those who had LNG-IUS placement within 3\u00a0months postoperatively regarding the incidence of adverse reactions. Preoperative endometrial thickness and maximum polyp diameter were the independent risk factors for the duration of irregular uterine bleeding after LNG-IUS insertion. Comprised preoperative endometrial thickness and maximum polyp diameter identified using logistic regression model and GAM model could predict the duration of IUBP effectively. The tenfold cross-validation showed that the GAM model (AUC 0.906) had slightly better predictive power than the bivariate logistic regression model (AUC 0.902).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Hysteroscopic polypectomy combined with LNG-IUS insertion was an effective measure to treat endometrial polyps. LNG-IUS intraoperative placement did not increase the incidence of adverse reactions. Preoperative endometrial thickness and maximum polyp diameter play a key role in valuable prediction for the duration of irregular uterine bleeding after LNG-IUS insertion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03776-w","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T13:16:26Z","timestamp":1767618986000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction of menstrual patterns and analysis of adverse effects for hysteroscopic endometrial polypectomy combined with LNG-IUS treatment: a single-center retrospective cohort study"],"prefix":"10.1186","volume":"31","author":[{"given":"Ruikun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanjia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6306-6419","authenticated-orcid":false,"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"4","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/13697137.2020.1742107","volume":"23","author":"KK Sheng","year":"2020","unstructured":"Sheng KK, Lyons SD. To treat or not to treat? An evidence-based practice guide for the management of endometrial polyps. Climacteric. 2020;23(4):336\u201342. https:\/\/doi.org\/10.1080\/13697137.2020.1742107.","journal-title":"Climacteric"},{"issue":"5","key":"3776_CR2","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/13645706.2021.1948867","volume":"30","author":"N Raz","year":"2021","unstructured":"Raz N, Feinmesser L, Moore O, Haimovich S. Endometrial polyps: diagnosis and treatment options - a review of literature. Minim Invasive Ther Allied Technol. 2021;30(5):278\u201387. https:\/\/doi.org\/10.1080\/13645706.2021.1948867.","journal-title":"Minim Invasive Ther Allied Technol"},{"issue":"1","key":"3776_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.19538\/j.fk2022080112","volume":"39","author":"W Tian","year":"2023","unstructured":"Tian W, Zhang H, Xue F. Interpretation of the Chinese expert consensus on diagnosis and treatment of endometrial polyps (2022 edition). Pract Obstet Gynecol. 2023;39(1):29\u201333. https:\/\/doi.org\/10.19538\/j.fk2022080112.","journal-title":"Pract Obstet Gynecol"},{"issue":"7","key":"3776_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3760\/cma.j.cn112141-20220422-00269","volume":"57","author":"JL Tong","year":"2022","unstructured":"Tong JL, Feng LM, Xue FX, et al. Clinical diagnosis and treatment pathway for endometrial polyps. Chin J Obstet Gynecol. 2022;57(7):491\u20135. https:\/\/doi.org\/10.3760\/cma.j.cn112141-20220422-00269.","journal-title":"Chin J Obstet Gynecol"},{"issue":"12","key":"3776_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3760\/cma.j.issn.0529-567x.2019.12.005","volume":"54","author":"JH Lang","year":"2019","unstructured":"Lang JH, Leng JH, Deng S, et al. Chinese expert consensus on the clinical application of levonorgestrel-releasing intrauterine system. Chin J Obstet Gynecol. 2019;54(12):815\u201325. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567x.2019.12.005.","journal-title":"Chin J Obstet Gynecol"},{"issue":"3","key":"3776_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3969\/j.issn.1009-6604.2013.03.018","volume":"13","author":"W Wang","year":"2013","unstructured":"Wang W, Wang XY. Effects of oral contraceptives or levonorgestrel-releasing intrauterine system on recurrence prevention after hysteroscopic endometrial polypectomy. Chin J Minim Invasive Surg. 2013;13(3):249-251,261. https:\/\/doi.org\/10.3969\/j.issn.1009-6604.2013.03.018.","journal-title":"Chin J Minim Invasive Surg"},{"issue":"22","key":"3776_CR7","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3969\/j.issn.1006-1959.2017.22.030","volume":"30","author":"WM Liu","year":"2017","unstructured":"Liu WM. Clinical effect of Mirena and Duphaston in preventing recurrence after endometrial polypectomy. Med Inform. 2017;30(22):69\u201371. https:\/\/doi.org\/10.3969\/j.issn.1006-1959.2017.22.030.","journal-title":"Med Inform"},{"issue":"5","key":"3776_CR8","first-page":"2319","volume":"34","author":"M Arnes","year":"2014","unstructured":"Arnes M, Hvingel B, Orbo A. Levonorgestrel-impregnated intrauterine device reduces occurrence of hyperplastic polyps: a population-based follow-up cohort study. Anticancer Res. 2014;34(5):2319\u201324.","journal-title":"Anticancer Res"},{"key":"3776_CR9","unstructured":"National Institute for Health and Care Excellence (NICE). Heavy menstrual bleeding: assessment and management. London: NICE; 2021 May 24. PMID: 29634173."},{"issue":"1","key":"3776_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","volume":"113","author":"MG Munro","year":"2011","unstructured":"Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age. Int J Gynaecol Obstet. 2011;113(1):3\u201313. https:\/\/doi.org\/10.1016\/j.ijgo.2010.11.011.","journal-title":"Int J Gynaecol Obstet"},{"key":"3776_CR11","unstructured":"Bayer HealthCare Pharmaceuticals Inc. Mirena (levonorgestrel-releasing intrauterine system) prescribing information. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc.; 2024. https:\/\/www.bayer.com\/en\/product-mirena"},{"key":"3776_CR12","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119848247","volume":"7","author":"NP Nijkang","year":"2019","unstructured":"Nijkang NP, Anderson L, Markham R, Manconi F. Endometrial polyps: pathogenesis, sequelae and treatment. SAGE Open Med. 2019;7:2050312119848247. https:\/\/doi.org\/10.1177\/2050312119848247.","journal-title":"SAGE Open Med"},{"issue":"11","key":"3776_CR13","doi-asserted-by":"publisher","first-page":"11628","DOI":"10.21037\/apm-21-2747","volume":"10","author":"J Liu","year":"2021","unstructured":"Liu J, Liang Y, Ouyang J, Yang S. Analysis of risk factors and model establishment of recurrence after endometrial polypectomy. Ann Palliat Med. 2021;10(11):11628\u201334. https:\/\/doi.org\/10.21037\/apm-21-2747.","journal-title":"Ann Palliat Med"},{"issue":"6","key":"3776_CR14","doi-asserted-by":"publisher","first-page":"821","DOI":"10.31083\/j.ceog.2020.06.5387","volume":"47","author":"Y Sun","year":"2020","unstructured":"Sun Y, Chen X, Yuan X, Xu L, Jin YC, Ji TH, et al. Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: a meta-analysis of 19 randomized controlled trials. Clin Exp Obstet Gynecol. 2020;47(6):821\u20138. https:\/\/doi.org\/10.31083\/j.ceog.2020.06.5387.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"12","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.3969\/j.issn.1004-8189.2019.12.011","volume":"27","author":"F Zhou","year":"2019","unstructured":"Zhou F, Shao J, Huang H. Effects and prognosis of different surgical approaches for the treatment of endometrial polyps under hysteroscopy. Chin J Fam Plan. 2019;27(12):1617\u20139. https:\/\/doi.org\/10.3969\/j.issn.1004-8189.2019.12.011.","journal-title":"Chin J Fam Plan"},{"issue":"1","key":"3776_CR16","first-page":"60","volume":"31","author":"M Yang","year":"2023","unstructured":"Yang M, Yang H, Wang T. Efficacy of hysteroscopic electrosurgical resection combined with Mifepristone in treating endometrial polyps and its effects on estrogen and progesterone receptor expression and inflammatory factors. Chin J Fam Plan. 2023;31(1):60-63.6.","journal-title":"Chin J Fam Plan"},{"issue":"4","key":"3776_CR17","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1080\/13697137.2020.1784870","volume":"23","author":"A Ludwin","year":"2020","unstructured":"Ludwin A, Lindheim SR, Booth R, Ludwin I. Removal of uterine polyps: clinical management and surgical approach. Climacteric. 2020;23(4):388\u201396. https:\/\/doi.org\/10.1080\/13697137.2020.1784870.","journal-title":"Climacteric"},{"issue":"2","key":"3776_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3760\/cma.j.issn.0529-567x.2015.02.001","volume":"50","author":"JH Lang","year":"2015","unstructured":"Lang JH, Leng JH, Xu Q, et al. Chinese expert consensus on the clinical application of combined oral contraceptives. Chin J Obstet Gynecol. 2015;50(2):81\u201391. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-567x.2015.02.001.","journal-title":"Chin J Obstet Gynecol"},{"issue":"5","key":"3776_CR19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.contraception.2016.06.013","volume":"94","author":"M Mejia","year":"2016","unstructured":"Mejia M, McNicholas C, Madden T, Peipert JF. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use. Contraception. 2016;94(5):556\u201360. https:\/\/doi.org\/10.1016\/j.contraception.2016.06.013.","journal-title":"Contraception"},{"issue":"3","key":"3776_CR20","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.contraception.2017.10.005","volume":"97","author":"PD Darney","year":"2018","unstructured":"Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception. 2018;97(3):210\u20134.","journal-title":"Contraception"},{"issue":"4S","key":"3776_CR21","doi-asserted-by":"publisher","first-page":"S888.e1","DOI":"10.1016\/j.ajog.2019.11.1288","volume":"222","author":"BA Chen","year":"2020","unstructured":"Chen BA, Eisenberg DL, Schreiber CA, Turok DK, Olariu AI, Creinin MD. Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding. Am J Obstet Gynecol. 2020;222(4S):S888.e1-S888.e6. https:\/\/doi.org\/10.1016\/j.ajog.2019.11.1288.","journal-title":"Am J Obstet Gynecol"},{"key":"3776_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114581","volume":"191","author":"S Fanse","year":"2022","unstructured":"Fanse S, Bao Q, Burgess DJ. Long-acting intrauterine systems: recent advances, current challenges, and future opportunities. Adv Drug Deliv Rev. 2022;191:114581. https:\/\/doi.org\/10.1016\/j.addr.2022.114581.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"3776_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2165\/00002018-199615060-00006","volume":"15","author":"F Sturridge","year":"1996","unstructured":"Sturridge F, Guillebaud J. A risk-benefit assessment of the levonorgestrel-releasing intrauterine system. Drug Saf. 1996;15(6):430\u201340. https:\/\/doi.org\/10.2165\/00002018-199615060-00006.","journal-title":"Drug Saf"},{"issue":"1","key":"3776_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/uog.6421","volume":"34","author":"BR Benacerraf","year":"2009","unstructured":"Benacerraf BR, Shipp TD, Bromley B. Three-dimensional ultrasound detection of abnormally located intrauterine contraceptive devices which are a source of pelvic pain and abnormal bleeding. Ultrasound Obstet Gynecol. 2009;34(1):110\u20135. https:\/\/doi.org\/10.1002\/uog.6421.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"6","key":"3776_CR25","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1097\/AOG.0000000000005000","volume":"140","author":"MS Anthony","year":"2022","unstructured":"Anthony MS, Zhou X, Schoendorf J, et al. Demographic, reproductive, and medical risk factors for intrauterine device expulsion. Obstet Gynecol. 2022;140(6):1017\u201330. https:\/\/doi.org\/10.1097\/AOG.0000000000005000.","journal-title":"Obstet Gynecol"},{"issue":"4","key":"3776_CR26","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0010-7824(96)00189-8","volume":"54","author":"J Suvisaari","year":"1996","unstructured":"Suvisaari J, L\u00e4hteenm\u00e4ki P. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception. 1996;54(4):201\u20138. https:\/\/doi.org\/10.1016\/s0010-7824(96)00189-8.","journal-title":"Contraception"},{"issue":"5","key":"3776_CR27","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/jog.12007","volume":"39","author":"D Kuzel","year":"2013","unstructured":"Kuzel D, Hrazdirova L, Kubinova K, et al. Hysteroscopic management of displaced levonorgestrel-releasing intrauterine system. J Obstet Gynaecol Res. 2013;39(5):1014\u20138. https:\/\/doi.org\/10.1111\/jog.12007.","journal-title":"J Obstet Gynaecol Res"},{"issue":"5","key":"3776_CR28","first-page":"529","volume":"38","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Wang YM. Expert guidelines on the diagnosis and treatment of malignant transformation of endometrial polyps (2022 edition). Chin J Pract Gynecol Obstet. 2022;38(5):529\u201333.","journal-title":"Chin J Pract Gynecol Obstet"},{"issue":"9","key":"3776_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012658.pub2","volume":"9","author":"T Mittermeier","year":"2020","unstructured":"Mittermeier T, Farrant C, Wise MR. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Cochrane Database Syst Rev. 2020;9(9):CD012658. https:\/\/doi.org\/10.1002\/14651858.CD012658.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6 Suppl","key":"3776_CR30","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1016\/j.contraception.2007.01.015","volume":"75","author":"A Guttinger","year":"2007","unstructured":"Guttinger A, Critchley HO. Endometrial effects of intrauterine levonorgestrel. Contraception. 2007;75(6 Suppl):S93\u20138.","journal-title":"Contraception"},{"issue":"1","key":"3776_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-4-S1-S5","volume":"4","author":"HO Critchley","year":"2006","unstructured":"Critchley HO, Kelly RW, Baird DT, Brenner RM. Regulation of human endometrial function: mechanisms relevant to uterine bleeding. Reprod Biol Endocrinol. 2006;4(1):S5. https:\/\/doi.org\/10.1186\/1477-7827-4-S1-S5.","journal-title":"Reprod Biol Endocrinol"},{"issue":"11","key":"3776_CR32","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1093\/humrep\/dey296","volume":"33","author":"K Papaikonomou","year":"2018","unstructured":"Papaikonomou K, Kopp Kallner H, S\u00f6derdahl F, et al. Mifepristone treatment prior to insertion of a levonorgestrel releasing intrauterine system for improved bleeding control - a randomized controlled trial. Hum Reprod. 2018;33(11):2002\u20139. https:\/\/doi.org\/10.1093\/humrep\/dey296.","journal-title":"Hum Reprod"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03776-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03776-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:40:04Z","timestamp":1770122404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03776-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03776-w","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of the First Affiliated Hospital of Chongqing Medical University (approval number: CY2024-592\u201302; approval date: 29 December 2024). The requirement for informed consent was waived by the ethics committee due to the use of anonymized retrospective data. All data were handled in accordance with institutional data protection guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study used anonymized patient data from hospital records, and no individual identities or personal details are disclosed in this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}